Cargando…
Detecting rifampin and isoniazid resistance in Mycobacterium tuberculosis direct from patient sputum using an automated integrated system
While there has been progress in detection of drug resistant tuberculosis globally, WHO estimates only about half of the patients with bacteriologically confirmed tuberculosis were tested for rifampicin resistance over the past two years. To close this drug resistance diagnostic gap, an expansion of...
Autores principales: | Colman, Rebecca E., Hagan, Christopher, Chiles, Peter, Seifert, Marva, Catanzaro, Donald G., Kukhtin, Alexander V., Norville, Ryan, Hauns, Laura, Bueno, Arial, Holmberg, Rebecca C., Cooney, Christopher G., Rodwell, Timothy C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891689/ https://www.ncbi.nlm.nih.gov/pubmed/35252594 http://dx.doi.org/10.1016/j.jctube.2022.100304 |
Ejemplares similares
-
Genetic Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis: A Systematic Review
por: Seifert, Marva, et al.
Publicado: (2015) -
Rapid Detection of Extensively Drug-Resistant Tuberculosis in Clinical Samples Using a Novel Tabletop Platform: Protocol for a Prospective Clinical Study
por: Hillery, Naomi, et al.
Publicado: (2021) -
The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
por: Somoskovi, Akos, et al.
Publicado: (2001) -
Minimum inhibitory concentrations of rifampin and isoniazid among multidrug and isoniazid resistant Mycobacterium tuberculosis in Ethiopia
por: Getahun, Muluwork, et al.
Publicado: (2022) -
Performance of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis and rifampin resistance in a low-incidence, high-resource setting
por: Rice, Jason P., et al.
Publicado: (2017)